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Background: Vascular complications (VCs) are lower with cardiac catheterization (CATH) and intervention (PCI) performed from the radial artery 
(RA) compared to the femoral artery (FA). Whether RA CATH and PCI are also more cost effective is uncertain.
Methods: 4,172 consecutive procedures (2,665 FA; 1,507 RA) were performed at a single center between 1/09 and 11/10 during a complete 
transition from FA to preferred RA CATH and PCI. Only emergent, STEMI, and CABG patients were excluded. In-lab procedural and in-hospital VC costs 
were assessed for propensity score matched CATH and PCI cases.
Results: RA and FA patients were well matched for clinical and procedural characteristics except: closure devices FA>>RA; and abciximab vs. 
eptifibatide FA>>RA PCI. PCI outcomes were similar. VC incidence was 0.3% RA CATH vs. 1.4% FA CATH (p=0.02) and 0.5% RA PCI vs. 1.6% FA PCI 
(p=0.18). Mean cost differences (RA minus FA) by procedure are shown in the figure.
Conclusion: Transition to preferred RA for CATH and PCI resulted in higher in-lab CATH costs, lower in-lab PCI costs, and lower VC costs for CATH 
and PCI compared to matched FA. The cost per VC avoided with RA CATH was $4,321, and RA was economically dominant compared to FA in PCI and 
CATH+PCI cases. These observations from selected patients with similar clinical and procedural characteristics indicate that CATH and PCI using a 
preferred RA strategy lower VCs and costs compared to FA patients, but this analysis was sensitive to closure equipment and type of in-lab drug use.
 
